IDENTIFICATION AND USE OF CYTOTOXIC T LYMPHOCYTE (CTL) ANTIGEN-SPECIFIC TARGET CELL KILLING ENHANCER AGENTS

摘要

The present invention relates to screening methods for identification of agents (e.g., small molecules) that modulate cytotoxic T lymphocyte antigen-specific target (e.g., tumor) cell killing, as well as to uses of compounds identified thereby as immunomodulatory, including use of EGFR inhibitors as immunomodulatory agents.